Loading insider details...
Beta
Latest Form 4 (Sep 8, 2026): Tax Withholding of 460 PHAT shares, $4.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax Withholding | 460 | $4.2K |
| Jul 16, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax Withholding | 1,555 | $17.2K |
| Mar 3, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 13,000 | n/a |
| Jan 23, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax Withholding | 776 | $10.6K |
| Dec 19, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Tax Withholding | 230 | $3.7K |
| Nov 5, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 524 | $7.1K |
| Sep 9, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 461 | $5.6K |
| Jul 18, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 1,692 | $14.2K |
| May 21, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 33,000 | n/a |